MB
MPM BioImpact’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4M | Hold |
100,415
| – | – | 5.27% | 2 |
|
|
2025
Q1 | $33.3M | Buy |
+100,415
| New | +$33.3M | 5.72% | 2 |
|
|
2024
Q4 | – | Sell |
-72,395
| Closed | -$15.4M | – | 50 |
|
|
2024
Q3 | $15.4M | Buy |
72,395
+1,210
| +2% | +$257K | 2.3% | 15 |
|
|
2024
Q2 | $19.9M | Buy |
71,185
+9,786
| +16% | +$2.74M | 3.1% | 6 |
|
|
2024
Q1 | $16.4M | Buy |
61,399
+20,489
| +50% | +$5.47M | 2.64% | 9 |
|
|
2023
Q4 | $9.47M | Buy |
40,910
+51
| +0.1% | +$11.8K | 2.21% | 16 |
|
|
2023
Q3 | $5.97M | Buy |
40,859
+2,848
| +7% | +$416K | 1.59% | 22 |
|
|
2023
Q2 | $8.78M | Buy |
38,011
+1,973
| +5% | +$456K | 1.77% | 17 |
|
|
2023
Q1 | $8.73M | Buy |
36,038
+9,265
| +35% | +$2.24M | 2.27% | 14 |
|
|
2022
Q4 | $7.77M | Sell |
26,773
-17,974
| -40% | -$5.22M | 2.02% | 14 |
|
|
2022
Q3 | $2.91M | Sell |
44,747
-253
| -0.6% | -$16.4K | 0.69% | 27 |
|
|
2022
Q2 | $3.22M | Buy |
+45,000
| New | +$3.22M | 0.89% | 25 |
|